Sort
16,300 grants matching “fatty liver disease”
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$762,621Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Maternal High Fat Diet and Melanocortin System in Offspring
$762,585Kevin L Grove · Oregon Health & Science University · R01 · FY2010 · DK
Lipid Nutrition and the Brain
$762,232Stanley I Rapoport · National Institute On Aging · ZIA · FY2013 · AG
A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease
$762,142D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2023 · TR
Conjugated bile acids as nutritionally re-programmable antihypertensive metabolites
$761,554Bina Joe · University Of Toledo Health Sci Campus · R01 · FY2025 · HL
Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy
$760,561Grace A McComsey · Case Western Reserve University · R01 · FY2022 · DK
Deep Phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 Human Knockouts and Population Based Studies
$760,417Danish Saleheen · University Of Pennsylvania · R01 · FY2019 · HL
Mechanisms for regulation of a novel class of anti-diabetic lipids
$760,278Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
Obesity, Inflammation, and Lung Injury After Lung Transplantation
$760,134David J. Lederer · Columbia University Health Sciences · R01 · FY2015 · HL
Food Prescriptions to Promote Affordable Diets that Meet RDAs Among Multi-Generational Latino Households
$760,088Deborah A Cohen · Children'S Hospital Of Los Angeles · P50 · FY2024 · MD
Mechanisms for regulation of a novel class of anti-diabetic lipids
$758,791Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2023 · DK
Technical Validation of MRI Biomarkers of Liver Fat
$758,139Claude B Sirlin · University Of California, San Diego · R01 · FY2010 · DK
The PRIORITY Study: from PRedIctiOn to pReventIon of youth-onset TYpe 2 diabetes
$758,056Sheela Natesh Magge · Johns Hopkins University · U01 · FY2024 · DK
Generating Exogenic Organs for Transplantation without the Use of Immunosuppression
$758,037Clifford J. Steer · University Of Minnesota · R01 · FY2023 · AI
Multi-omics for obesity-associated liver disease discovery in Hispanics/Latinos: the Cameron County Hispanic Cohort
$758,005Joseph B. McCormick · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · CA
HT Image Assay of Lipid Droplet Formation in Human Adipocytes
$757,726Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2008 · DK
Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease
$757,122Carlos Fernandez Hernando · Yale University · R01 · FY2025 · HL
Caregivers as the Agent of Change for Childhood Obesity and Chronic Disease Risk Among Latino Families
$757,015Kerri N Boutelle · Children'S Hospital Of Los Angeles · P50 · FY2021 · MD
Nonlipogenic ABCA1 inducers for ADRD
$756,926Gregory R J Thatcher · University Of Arizona · U01 · FY2022 · AG
Symptom Distress Mechanisms in Digestive Disorders
$756,530Wendy Henderson · National Institute Of Nursing Research · ZIA · FY2016 · NR
Mechanism and inhibition of SREBP-dependent cholesterol/lipid metabolism
$756,148Gerhard Wagner · Harvard Medical School · R01 · FY2015 · HL
Intersection of Exercise and Estrogen in Weight Regain After Weight Loss
$755,422Paul S Maclean · University Of Colorado Denver · U54 · FY2024 · AG
Lead Optimization of Novel Inhibitors of the Thioesterase Domain of FASN
$755,282Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
Lead Optimization of Novel Inhibitors of the Thioesterase Domain of FASN
$755,282Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Lead Optimization of Novel Inhibitors of the Thioesterase Domain of FASN
$755,282Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA